Stock Market News

CNS Pharmaceuticals shares tumble after clinical trial results

Mar 25, 2025 - 13:47
 0
CNS Pharmaceuticals shares tumble after clinical trial results
Read More

Tags:

Previous Article

Cassava Sciences stock tumbles after Alzheimer's drug fails key study

Next Article

UBS sees improving outlook for European steel stocks

Related Posts

Fraport posts record revenue and profit despite market challenges in 2024

Fraport posts record revenue and profit despite market ...

Mar 18, 2025  0

Fitch affirms Poland's 'A-' rating with stable outlook

Fitch affirms Poland's 'A-' rating with stable outlook

Mar 17, 2025  0

German shares rise ahead of vote on debt reforms

German shares rise ahead of vote on debt reforms

Mar 18, 2025  0